FdaApplication
ANDA 203269
Identifiers
- fda_app_no: ANDA203269
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2016-02-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET;ORAL |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET;ORAL |
2 products